CHAPEL HILL, N.C., Dec. 1, 2017 /PRNewswire/ — Pharmaceutical companies are investing more resources in investigator initiated trials (IITs) as they strive to expand their commercial opportunities.
Yet as organizations strive to improve and expand their IIT programs, they are…
